Elif Erturk
Bursa, 16059, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Promoter Methylation and Somatic Mutations in Cancer-Related Genes Are Associated with Hyperprogressive Disease in Patients with Malignant Melanoma and Renal Cell Carcinoma Receiving Anti-PD-1/PD-L1 Immunotherapy.
Journal: Journal of clinical medicine
Published: March 31, 2026
Repurposing diclofenac for combination therapy: targeting the Warburg effect to enhance breast cancer treatment.
Journal: Turkish journal of medical sciences
Published: November 27, 2025
A New Treatment Strategy for Lung Cancer With HDAC and Wnt/β-Catenin Pathway Inhibitors.
Journal: IUBMB life
Published: January 02, 2025
Correction: Value of miR-31 and mir-150-3p as diagnostic and prognostic biomarkers for breast cancer.
Journal: Molecular biology reports
Published: October 22, 2024
Resveratrol modulates triosephosphate isomerase and mineralization in osteosarcoma cells: potential target for novel therapeutic strategies.
Journal: Turkish journal of biology = Turk biyoloji dergisi
Published: October 08, 2024
Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer.
Journal: Molecular biology reports
Published: March 04, 2024
Targeting the epithelial-mesenchymal transition (EMT) pathway with combination of Wnt inhibitor and chalcone complexes in lung cancer cells.
Journal: Journal of cellular biochemistry
Published: April 17, 2023
Soloxolone methyl induces apoptosis and oxidative/ER stress in breast cancer cells and target cancer stem cell population.
Journal: Turkish journal of biology = Turk biyoloji dergisi
Published: October 03, 2022
Mitochondrial miRNAs (MitomiRs): Their potential roles in breast and other cancers.
Journal: Mitochondrion
Published: May 06, 2022
Investigation of the efficacy of paclitaxel on some miRNAs profiles in breast cancer stem cells.
Journal: Turkish journal of biology = Turk biyoloji dergisi
Published: March 17, 2021
Combination of Histone Deacetylase Inhibitor with Cu(II) 5,5-diethylbarbiturate Complex Induces Apoptosis in Breast Cancer Stem Cells: A Promising Novel Approach.
Journal: Anti-cancer agents in medicinal chemistry
Published: May 18, 2020
Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Journal: Chemico-biological interactions
Published: September 27, 2017
Last Updated: 09/26/2026